How does Ebola cause lymphopenia?
Researchers may have discovered how Ebola invades our immune system and disrupts the host immune response.
Browsing: Ebola
Second Ebola vaccine to be introduced in the DRC
Health authorities in the Democratic Republic of Congo plan to introduce a second experimental Ebola vaccine, manufactured by Johnson & Johnson, from mid-October.
Mortality rates in Ebola survivors reported to be five-times higher than the general population
The results of a new study suggest that – compared with the general population – Ebola survivors may be at a significantly increased risk of death, particularly during the first year following hospital discharge.
Two Ebola treatments prove effective in DRC outbreak
A study of four Ebola therapeutics demonstrated that two drugs showed significantly improved survival rates, leading to the trial being halted early.
One year into the DRC Ebola outbreak – is there an end in sight?
The outbreak of Ebola in the Democratic Republic of Congo has seen over 2612 cases and 1756 mortalities since it was first announced by the WHO on 1 August 2018. One year on we ask, what have the major milestones been of this outbreak? And where are we now; is there an end in sight?
Ebola outbreak declared a Public Health Emergency of International Concern
The fourth International Health Regulations Emergency Committee meeting has concluded by declaring a Public Health Emergency of International Concern, following the recent Ebola virus disease outbreak in the Democratic Republic of the Congo.
Cases of Ebola confirmed in Uganda
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
ECCMID19: Immune response to Ebola 2 years post-infection could provide clues for vaccine development
Two years after Ebola infection, survivors exhibit specific memory T cell responses against ebolavirus, according to new research presented at ECCMID.
Bombali ebolavirus discovered in bats in Kenya
A recently discovered species of the ebolavirus, the Bombali virus, has been identified in bats in Kenya, marking the first time any ebolavirus has been found in wildlife on the east coast of Africa.
Institutional trust and misinformation: the impact on Ebola control efforts
A new population-based survey has reported that low levels of public trust could have impacted the Ebola control efforts in the Democratic Republic of Congo, with a quarter of individuals not believing the virus was real and refusing vaccination.
